Published in Br Med J (Clin Res Ed) on June 27, 1987
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care (1999) 8.33
Microalbuminuria. BMJ (1992) 1.35
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Microproteinuria: response to operation. Br Med J (Clin Res Ed) (1988) 1.04
Outcome of renal replacement treatment in patients with diabetes mellitus. BMJ (1990) 0.85
Diabetes Dyslipidemia. Diabetes Ther (2016) 0.85
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
Triglycerides and disease. Postgrad Med J (1993) 0.75
Specific lipid lowering therapy in the management of diabetes. Postgrad Med J (1991) 0.75
Proteinuria in malignancy. Br Med J (Clin Res Ed) (1988) 0.75
Coronary heart disease in diabetes mellitus--antecedents and associations. Postgrad Med J (1991) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest (1955) 31.08
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res (1970) 9.50
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1985) 3.75
Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med (1980) 2.96
Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia (1984) 2.50
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98
Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem (1983) 1.77
Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia (1986) 1.61
Mortality experience of diabetic patients. A twenty-six-year follow-up study. Am J Med (1971) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Smoking and diabetic microangiopathy. Lancet (1978) 1.43
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia (1986) 1.26
Pregnancy during residency. N Engl J Med (1986) 1.22
Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1984) 1.22
Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med (1980) 1.11
Enzyme immunoassay for urinary albumin. Clin Chem (1983) 1.06
Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia (1985) 1.05
Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet (1986) 1.04
Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 0.95
Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes (1978) 0.93
The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care (1985) 0.91
Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs. Diabetes (1982) 0.91
A comparison of methods for the immunoassay of serum apolipoprotein B in man. Clin Chim Acta (1976) 0.89
Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia (1982) 0.89
Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care (1984) 0.88
Mortality and associated risk factors in diabetics. Acta Endocrinol Suppl (Copenh) (1985) 0.87
Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand (1984) 0.86
Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin Chim Acta (1980) 0.86
High density lipoproteins in diabetes. Diabetes (1981) 0.84
The nephrotic syndrome and ischaemic heart disease. Nephron (1981) 0.83
Coagulability in diabetics. Acta Med Scand Suppl (1967) 0.81
Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins. Metabolism (1982) 0.81
Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care (1982) 0.80
Lipid structure and the behavior of cholesteryl esters in monolayer and bulk phases. J Lipid Res (1979) 0.80
A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabetics. Ann Clin Biochem (1980) 0.78
Serum high density lipoprotein cholesterol subfractions in type I (insulin-dependent) diabetes mellitus. Clin Chim Acta (1982) 0.78
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med (1987) 6.45
Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest (1989) 5.97
Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet (1995) 5.79
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28
Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest (1988) 4.22
The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis (1985) 4.08
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet (2000) 3.73
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol (1986) 3.35
Renal function during antihypertensive treatment. Lancet (1995) 3.33
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med (1984) 3.14
Sex-hormone-binding globulin. Clin Endocrinol (Oxf) (1974) 3.11
Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett (1991) 3.10
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82
Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest (1991) 2.77
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest (1984) 2.57
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J (1996) 2.55
Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest (1991) 2.50
Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses (1989) 2.50
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis (1993) 2.48
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44
Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg (1992) 2.41
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Airborne spread of brucellosis. Ann N Y Acad Sci (1980) 2.33
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut (2000) 2.30
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol (1990) 2.24
Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell (1987) 2.23
Guidelines for the clinical use of red cell transfusions. Br J Haematol (2001) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG (2013) 2.16
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol (1989) 2.09
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke (1995) 2.08
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.05
Methods for managing the increased workload in anticoagulant clinics. BMJ (1996) 2.03
Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol (1997) 1.99
Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone. Ann Rheum Dis (1986) 1.97
A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis. J Cell Biol (1989) 1.95
Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr (1981) 1.94
Prevention of macrovascular disease: absolute proof or absolute risk? Diabet Med (1995) 1.93
Heterogeneity of expression of E- and P-selectins in vivo. Circ Res (1996) 1.91
Inflammation in the course of early myocardial ischemia. FASEB J (1991) 1.90
E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest (1993) 1.90
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med (1996) 1.88
Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration. Ann Surg (1991) 1.88
Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest (1995) 1.85
Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol (1998) 1.84
Human leptospirosis. CRC Crit Rev Clin Lab Sci (1975) 1.82
Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens (2002) 1.81
Botulinum toxin treatment of spasmodic torticollis. J R Soc Med (1992) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ (2000) 1.80
Pontiac fever: isolation of the etiologic agent (Legionella pneumophilia) and demonstration of its mode of transmission. Am J Epidemiol (1981) 1.77
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet (2006) 1.76
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76
Estimated 10-year cardiovascular risk in a British population: results of a national screening project. Int J Clin Pract (2008) 1.75
Wrong lesson from Finnish trial of cardiovascular disease prevention. Lancet (1992) 1.74
Beta 2-integrin and L-selectin are obligatory receptors in neutrophil aggregation. Blood (1993) 1.74
Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys (1987) 1.73
Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. Rheumatology (Oxford) (2003) 1.72
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg (1995) 1.71
Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides). J Infect Dis (1987) 1.70
Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family. J Clin Invest (1989) 1.70
Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro. Blood (1991) 1.69
A simple method for the assay of eight steroids in small volumes of plasma. Steroids (1976) 1.69
Dominant effector genetics in mammalian cells. Nat Genet (2001) 1.68
zFP538, a yellow-fluorescent protein from Zoanthus, contains a novel three-ring chromophore. Biochemistry (2005) 1.67
Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol (1997) 1.66
Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol (1997) 1.66
Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res (1998) 1.65
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res (1994) 1.64
Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA (1989) 1.64
Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A (1986) 1.63
Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine. J Clin Invest (1981) 1.62